Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
References
Gottlieb J, Simon S, Barton J, et al. Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation: a two center cohort study during the omicron era. Infection. 2023;51:1481–9.
Vanlerberghe B, Vrij C, Bogaerts K, et al. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients. J Med Virol. 2023;95:e28736.
Bruel T, Hadjadj J, Maes P, et al. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies. Nat Med. 2022;6:1297.
Touret F, Baronti C, Pastorino B, et al. In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5. Sci Rep. 2022;12:12609.
de Lamballerie X, Martin-Blondel G, Dupont A, et al. Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation. J Infect. 2023;86:66–117.
Gallian P, Pastorino B, Morel P, Chiaroni J, Ninove L, de Lamballerie X. Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Antiviral Res. 2020;181: 104880.
Acknowledgements
The authors thank the clinicians of the pneumology ward: Dr. Berengère Coltey, Dr. Nadine Dufeu, Dr. Julien Bermudez, Dr Ana Nieves, and Dr Clarisse Gautier.
Funding
None.
Author information
Authors and Affiliations
Contributions
Carole Eldin performed statistical analysis of data, interpreted the analysis and wrote the MS. Elif Nurtop, Stephane Priet and Karine Barthelemy performed the technical analysis of samples. Laetitia Ninove supervised the technical analysis of samples. Benjamin Coiffard and Martine Reynaud-Gaubert organized the data collection and the retrospective analysis of patient’s data. Benjamin Coiffard reviewed and corrected the final version of the MS. Nathalie Colombini provided the data about Evusheld and Ronapreve authorization and prescribed doses and corrected the final version of the MS. Xavier de Lamballerie designed the study, supervised the data interpretation, and reviewed and corrected the final version of the MS.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Eldin, C., Nurtop, E., Coiffard, B. et al. Correspondence: serum neutralization of SARS-CoV-2 Omicron sublineages BA.1, BA.2 and BA.5 in lung transplant recipients receiving prophylactic tixagevimab/cilgavimab. Infection (2024). https://doi.org/10.1007/s15010-024-02258-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-024-02258-1